ArticleJournal of chemical information and modeling2021
Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts.
Article in Journal of chemical information and modeling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Knowledge mapping of graph neural networks for drug discovery: a bibliometric and visualized analysis.Frontiers in pharmacology · 2024Pooled it
- An interpretable framework applying protein words to predict protein-small molecule complementary pairing rules.Chemical science · 2026Article
- Research Progress in Artificial Intelligence-Assisted Preparation of High-Quality Biomaterials.ACS omega · 2026Review
- Generalizable compound protein interaction prediction with a model incorporating protein structure aware and compound property aware language model representations.Communications chemistry · 2025Article
- KGG: Knowledge-Guided Graph Self-Supervised Learning to Enhance Molecular Property Predictions.Journal of chemical information and modeling · 2025Article
- A review of deep learning methods for ligand based drug virtual screening.Fundamental research · 2024Review
- A comprehensive review of the recent advances on predicting drug-target affinity based on deep learning.Frontiers in pharmacology · 2024Review
- Machine Learning-Enabled Genome Mining and Bioactivity Prediction of Natural Products.ACS synthetic biology · 2023Review
- Interpretable Machine Learning of Amino Acid Patterns in Proteins: A Statistical Ensemble Approach.Journal of chemical theory and computation · 2023Article
- Graph Domain Adaptation via Theory-Grounded Spectral Regularization.... International Conference on Learning Representations · 2023Article
- Cross-modality and self-supervised protein embedding for compound-protein affinity and contact prediction.Bioinformatics (Oxford, England) · 2022Article
- Mechanistic Insights into Enzyme Catalysis from Explaining Machine-Learned Quantum Mechanical and Molecular Mechanical Minimum Energy Pathways.ACS physical chemistry Au · 2022Article
- Sequence-based prediction of protein binding regions and drug-target interactions.Journal of cheminformatics · 2022Article
- MGraphDTA: deep multiscale graph neural network for explainable drug-target binding affinity prediction.Chemical science · 2022Article
- Comprehensive Survey of Recent Drug Discovery Using Deep Learning.International journal of molecular sciences · 2021Review
- MCN-CPI: Multiscale Convolutional Network for Compound-Protein Interaction Prediction.Biomolecules · 2021Article
- A review on compound-protein interaction prediction methods: Data, format, representation and model.Computational and structural biotechnology journal · 2021Review
- Knowledge-primed neural networks enable biologically interpretable deep learning on single-cell sequencing data.Genome biology · 2020Article
- When Does Self-Supervision Help Graph Convolutional Networks?Proceedings of machine learning research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Predicting compound-protein affinity is beneficial for accelerating drug discovery. Doing so without the often-unavailable structure data is gaining interest. However, recent progress in structure-free affinity prediction, made by machine learning, focuses on accuracy but leaves much to be desired for interpretability. Defining intermolecular contacts underlying affinities as a vehicle for interpretability; our large-scale interpretability assessment finds previously used attention mechanisms inadequate. We thus formulate a hierarchical multiobjective learning problem, where predicted contacts form the basis for predicted affinities. We solve the problem by embedding protein sequences (by hierarchical recurrent neural networks) and compound graphs (by graph neural networks) with joint attentions between protein residues and compound atoms. We further introduce three methodological advances to enhance interpretability: (1) structure-aware regularization of attentions using protein sequence-predicted solvent exposure and residue-residue contact maps; (2) supervision of attentions using known intermolecular contacts in training data; and (3) an intrinsically explainable architecture where atomic-level contacts or "relations" lead to molecular-level affinity prediction. The first two and all three advances result in DeepAffinity+ and DeepRelations, respectively. Our methods show generalizability in affinity prediction for molecules that are new and dissimilar to training examples. Moreover, they show superior interpretability compared to state-of-the-art interpretable methods: with similar or better affinity prediction, they boost the AUPRC of contact prediction by around 33-, 35-, 10-, and 9-fold for the default test, new-compound, new-protein, and both-new sets, respectively. We further demonstrate their potential utilities in contact-assisted docking, structure-free binding site prediction, and structure-activity relationship studies without docking. Our study represents the first model development and systematic model assessment dedicated to interpretable machine learning for structure-free compound-protein affinity prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.